Jigsawdio Multisensory Platform for People With Mild Cognitive Impairment, Alzheimer's Disease, or Related Dementias

N/ANot Yet RecruitingNCT07839286

Callahan-Young LLC DBA Jigsawdio80 enrolled

Overview

This study will evaluate Jigsawdio, a personalized multisensory jigsaw puzzle platform, for adults aged 60 years and older with mild cognitive impairment or mild dementia. Approximately 80 participants will be randomly assigned to either the Jigsawdio group or a control group using standard dementia-friendly jigsaw puzzles. Both groups will complete two 30- to 40-minute puzzle sessions per week for six weeks, for a total of 12 sessions. Jigsawdio combines transparent physical puzzle pieces with personalized images, stories, and audio presented through an iPad. The study will compare changes in depression, anxiety, quality of life, cognition, engagement, satisfaction, and program feasibility. Assessments will be completed at baseline, after the six-week program, and at a 12-week follow-up. Information may also be collected from participants' caregivers or informants.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Alzheimer Disease Dementia Mild Cognitive Impairment

Interventions

Jigsawdio Multisensory Puzzle PlatformBEHAVIORAL

Jigsawdio is a personalized multisensory puzzle platform that combines transparent physical puzzle pieces with images, stories, and audio presented through an iPad. Participants will complete two approximately 30- to 40-minute Jigsawdio sessions per week for six weeks, for a total of 12 sessions.

Standard Jigsaw Puzzle ActivityBEHAVIORAL

Participants will complete two approximately 30- to 40-minute standard jigsaw puzzle sessions per week for six weeks, for a total of 12 sessions. Commercially available dementia-friendly puzzles will be used as the comparison activity.

Eligibility

Sex: ALLMin age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age: 60 years or older. 2. Able to communicate fluently in English. 3. Mild cognitive impairment or mild dementia based on an existing diagnosis or study screening procedures. 4. Has an informant and a puzzle creator who know the participant and are willing to participate in the study; the same person may serve in both roles. Exclusion Criteria: 1. Severe uncorrected visual or hearing impairment that would prevent puzzle use. 2. Severe motor impairment that would prevent puzzle use. 3. Concurrent participation in a similar program or Alzheimer's disease intervention study. 4. Current hospice care or terminal illness. 5. Plans to relocate within three months after the baseline assessment. 6. History of a serious mental illness, such as bipolar disorder or schizophrenia, that would interfere with study participation. 7. Unable to provide informed consent and no legally authorized representative is available

Locations (2)

Duke University

Durham, North Carolina, United States

Texas A&M University

College Station, Texas, United States

Outcomes

Primary Outcomes

Change in Quality of Life Measured by the Quality of Life in Alzheimer's Disease Scale

Quality of life will be measured using the Quality of Life in Alzheimer's Disease scale (QoL-AD). Total scores range from 13 to 52, with higher scores indicating better quality of life.